Submitted:
19 September 2024
Posted:
20 September 2024
Read the latest preprint version here
Abstract
Keywords:
1. Background
2. Health Economics Evaluation Framework

3. Methods and Data

- EuroQoL EQ-5D-5L,
- Visual analogue scale (VAS) for overall health state (ranging between 0 ‘worst’ and 100 ‘best’ health imaginable), and
- Wellbeing scores (life satisfaction, worthwhileness, happiness and anxiousness), all measured on 0 to 10 scale and adapted from the Office for National Statistics, (2012).
4. Association of Financial Distress with QoL and Wellbeing of Informal Carers



5. Impact (Determinants) of Financial Distress on QoL and Wellbeing of PwPs

6. Limitations of the Study
7. Key Findings and Policy Recommendations
References
- Bhimani, R. Understanding the Burden on Caregivers of People with Parkinson’s: A Scoping Review of the Literature. Rehabilitation Research and Practice 2014, 2014, 718527. [Google Scholar] [CrossRef] [PubMed]
- Chaudhuri, K.R.; Azulay, J.-P.; Odin, P.; Lindvall, S.; Domingos, J.; Alobaidi, A.; Kandukuri, P.L.; Chaudhari, V.S.; Parra, J.C.; Yamazaki, T.; Oddsdottir, J.; Wright, J.; Martinez-Martin, P. Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study. Drugs - Real World Outcomes 2024, 11, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Cholewa, J.; Gorzkowska, A.; Szepelawy, M.; Nawrocka, A.; Cholewa, J. Influence of functional movement rehabilitation on quality of life in people with Parkinson’s disease. Journal of Physical Therapy Science 2014, 26, 1329–1331. [Google Scholar] [CrossRef] [PubMed]
- Devlin, N. J.; Brooks, R. EQ-5D and the EuroQol Group: Past, Present and Future. Applied Health Economics and Health Policy 2017, 15, 127–137. [Google Scholar] [CrossRef]
- Devlin, N.; Shah, K.; Feng, Y.; Mulhern, B.; van Hout, B. Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England: Vol. Research Paper 16/01. Office of Health Economics. 2016. [Google Scholar]
- Dodel, R.; Tinelli, M.; Deuschl, G.; Petersen, G.; Oertel, W.; Ahmerkamp-Böhme, J. The economic benefit of timely, adequate, and adherence to Parkinson’s disease treatment: The Value of Treatment Project 2. European Journal of Neurology 2021, 28, 707–716. [Google Scholar] [CrossRef]
- EuroQol Research Foundation. EQ-5D-5L User Guide [Dataset]. https://euroqol.org/publications/user-guides. 2019. [Google Scholar]
- Findley, L.; Aujla, M.; Bain, P.G.; Baker, M.; Beech, C.; Bowman, C.; Holmes, J.; Kingdom, W.K.; MacMahon, D.G.; Peto, V.; Playfer, J.R. Direct economic impact of Parkinson’s disease: A research survey in the United Kingdom. Movement Disorders 2003, 18, 1139–1145. [Google Scholar] [CrossRef]
- Findley, L.J. The economic impact of Parkinson’s disease. Parkinson’s Disease: From Premotor Symptoms to New Treatment Strategies 2007, 13, S8–S12. [Google Scholar] [CrossRef]
- Findley, L.J.; Wood, E.; Lowin, J.; Roeder, C.; Bergman, A.; Schifflers, M. The economic burden of advanced Parkinson’s disease: An analysis of a UK patient dataset. Journal of Medical Economics 2011, 14, 130–139. [Google Scholar] [CrossRef]
- Giles, M.; Thomas, M.; Lewin, G. Ageing Intensifies the Care Needs of Adults Living with Parkinson ’s Disease and their Carers. Ageing International 2015, 40, 338–352. [Google Scholar] [CrossRef]
- Gumber, A.; Ramaswamy, B.; Ibbotson, R.; Ismail, M.; Thongchundee, O.; Harrop, D.; Allmark, P.; Rauf, A. Economic, Social and Financial Cost of Parkinson’s on Individuals, Carers and their Families in the UK. Centre for Health and Social Care Research, Sheffield Hallam University. https://shura.shu.ac.uk/15930/. 2017. [Google Scholar]
- Gumber, A.; Ramaswamy, B.; Thongchundee, O. Effects of Parkinson’s on employment, cost of care, and quality of life of people with condition and family caregivers in the UK: a systematic literature review. Patient Related Outcome Measures 2019, 10, 321–333. [Google Scholar] [CrossRef]
- Henry, R.S.; Lageman, S.K.; Perrin, P.B. The relationship between Parkinson’s disease symptoms and caregiver quality of life. Rehabilitation Psychology 2020, 65, 137–144. [Google Scholar] [CrossRef] [PubMed]
- Janssen Daalen, J.M.; Schootemeijer, S.; Richard, E.; Darweesh SK, L.; Bloem, B.R. Lifestyle Interventions for the Prevention of Parkinson Disease. Neurology 2022, 99, 42–51. [Google Scholar] [CrossRef]
- Marras, C.; Canning, C.G.; Goldman, S.M. Environment, lifestyle, and Parkinson’s disease: Implications for prevention in the next decade. Movement Disorders 2019, 34, 801–811. [Google Scholar] [CrossRef]
- McCrone, P.; Allcock, L.M.; Burn, D.J. Predicting the cost of Parkinson’s disease. Movement Disorders 2007, 22, 804–812. [Google Scholar] [CrossRef] [PubMed]
- Modugno, N.; Antonini, A.; Tessitore, A.; Marano, P.; Pontieri, F.E.; Tambasco, N.; Canesi, M.; Fabbrini, G.; Sensi, M.; Quatrale, R.; Solla, P.; Defazio, G.; Melzi, G.; Gualberti, G.; Lopiano, L. Impact of Supporting People with Advanced Parkinson’s Disease on Carer’s Quality of Life and Burden. Neuropsychiatric Disease and Treatment 2020, 16, 2899–2912. [Google Scholar] [CrossRef] [PubMed]
- Moreira, R. C.; Zonta, M. B.; Araújo, A. P. S. de; Israel, V. L.; Teive, H. A. G. Quality of life in Parkinson’s disease patients: Progression markers of mild to moderate stages. Arquivos de Neuro-Psiquiatria 2017, 75. [Google Scholar] [CrossRef] [PubMed]
- Office for National Statistics. First Annual ONS Experimental Subjective Well-being Results. https://webarchive.nationalarchives.gov.uk/ukgwa/20160106195128/http://www.ons.gov.uk/ons/rel/wellbeing/measuring-subjective-wellbeing-in-the-uk/first-annual-ons-experimental-subjective-well-being-results/first-ons-annual-experimental-subjective-well-being-results.html. 2012. [Google Scholar]
- Parkinson’s Community Help. "The Parkinson’s Journey: Understanding Progression” – Webinar Notes. Stanford Medicine: Stanford PD Community Blog. https://parkinsonsblog.stanford.edu/2021/09/the-parkinsons-journey-understanding-progression-webinar-notes/. 2021. [Google Scholar]
- Parkinson’s UK. The cost of Parkinson’s: The financial impact of living with the condition. https://www.parkinsons.org.uk/sites/default/files/2017-07/CS2547%20Cost%20of%20Parkinson%27s%20report%202017%20-%20UK_1.pdf. 2023. [Google Scholar]
- Pontone, G.M.; Dissanayaka, N.; Dobkin, R.D.; Mari, L.; Marsh, L.; Vernaleo, B.A.; Weintraub, D.; Mari, Z. Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease. Innovations and Challenges of Training in Geriatric Mental Health 2019, 27, 712–719. [Google Scholar] [CrossRef]
- Rahman, S.; Griffin, H.J.; Quinn, N.P.; Jahanshahi, M. Quality of life in Parkinson’s disease: The relative importance of the symptoms. Movement Disorders 2008, 23, 1428–1434. [Google Scholar] [CrossRef]
- Rosqvist, K.; Schrag, A.; Odin, P.; the CLaSP Consortium. Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease. Brain Sciences 2022, 12. [Google Scholar] [CrossRef]
- Santos-García, D.; de Deus Fonticoba, T.; Cores Bartolomé, C.; Íñiguez Alvarado, M. C.; Feal Panceiras, M. J.; Suárez Castro, E.; Canfield, H.; Martínez Miró, C.; Jesús, S.; Aguilar, M.; et al. Predictors of the change in burden, strain, mood, and quality of life among caregivers of Parkinson’s disease patients. International Journal of Geriatric Psychiatry 2022, 37. [Google Scholar] [CrossRef]
- Schrag, A.; Jahanshahi, M.; Quinn, N. What contributes to quality of life in patients with Parkinson’s disease? Journal of Neurology, Neurosurgery & Psychiatry 2000, 69, 308. [Google Scholar] [CrossRef] [PubMed]
- Tomlinson, C.L.; Patel, S.; Meek, C.; Herd, C.P.; Clarke, C.E.; Stowe, R.; Shah, L.; Sackley, C.; Deane KH, O.; Wheatley, K.; Ives, N. Physiotherapy intervention in Parkinson’s disease: Systematic review and meta-analysis. BMJ (Clinical Research Ed.) 2012, 345, e5004. [Google Scholar] [CrossRef] [PubMed]
- Trend, P.; Kaye, J.; Gage, H.; Owen, C.; Wade, D. Short-term effectiveness of intensive multidisciplinary rehabilitation for people with Parkinson’s disease and their carers. Clinical Rehabilitation 2002, 16, 717–725. [Google Scholar] [CrossRef] [PubMed]
- Veronese, N.; Nova, A.; Fazia, T.; Riggi, E.; Yang, L.; Piccio, L.; Huang, B.-H.; Ahmadi, M.; Barbagallo, M.; Notarnicola, M.; Giannelli, G.; De Pergola, G.; Stamatakis, E.; Cereda, E.; Bernardinelli, L.; Fontana, L. Contribution of Nutritional, Lifestyle, and Metabolic Risk Factors to Parkinson’s Disease. Movement Disorders 2024, 39, 1203–1212. [Google Scholar] [CrossRef]
- Weir, S.; Samnaliev, M.; Kuo, T.-C.; Tierney, T.S.; Walleser Autiero, S.; Taylor, R.S.; Schrag, A. Short- and long-term cost and utilization of health care resources in Parkinson’s disease in the UK. Movement Disorders 2018, 33, 974–981. [Google Scholar] [CrossRef]
| Respondent Characteristics | PwP | Carers | ||
|---|---|---|---|---|
| N | Percentage | N | Percentage | |
| Gender | ||||
| Male | 472 | 60.8 | 174 | 31.9 |
| Female | 298 | 38.4 | 364 | 66.7 |
| Others / Preferred not to say | 1 | 0.1 | 8 | 1.5 |
| No response | 5 | 0.6 | ||
| Marital Status | ||||
| Single / widowed / divorced separated/ other | 156 | 20.1 | 72 | 13.2 |
| Married / cohabiting | 610 | 78.6 | 465 | 85.2 |
| No response | 10 | 1.3 | 9 | 1.6 |
| Education | ||||
| All except higher education | 420 | 54.1 | 296 | 54.2 |
| Higher education | 345 | 44.5 | 344 | 43.4 |
| No response | 11 | 1.4 | 13 | 2.4 |
| Ethnic Group | ||||
| White | 714 | 92.0 | 504 | 92.3 |
| Non-white (including others) | 41 | 5.3 | 37 | 4.7 |
| No response | 21 | 2.7 | 5 | 0.9 |
| House Ownership | ||||
| Owned | 569 | 73.3 | ||
| Not owned | 102 | 13.2 | ||
| No response | 105 | 13.5 | ||
| Employment | ||||
| Working | 95 | 12.39 | 169 | 31.24 |
| Non-working (including others) | 568 | 74.05 | 305 | 56.38 |
| No response | 3 | 0.39 | 15 | 2.77 |
| Income Group | ||||
| < £10000 | 114 | 21.8 | 116 | 29 |
| £10000-£19999 | 180 | 34.4 | 124 | 31 |
| £20000-£29999 | 100 | 19.1 | 59 | 14.7 |
| £30000-£39999 | 47 | 9 | 37 | 9.3 |
| £40000-£49999 | 31 | 5.9 | 15 | 3.8 |
| £50000 or more | 25 | 4.8 | 23 | 5.7 |
| Don’t know | 26 | 5.0 | 26 | 6.5 |
| Duration since Diagnosis of Parkinson’s | ||||
| Up to 2 years | 84 | 10.82 | ||
| 2.1-5 years | 155 | 19.97 | ||
| 5.1-10 years | 253 | 32.60 | ||
| 10.1-15 years | 130 | 16.75 | ||
| 15.1-20 years | 65 | 8.38 | ||
| More than 20 years | 37 | 4.77 | ||
| Not recorded | 52 | 6.70 | ||
| Sr. No. | Socioeconomic factors | QoL | VAS | Life Satisfaction | Happiness | ||||
|---|---|---|---|---|---|---|---|---|---|
| Beta Coef. | Sig. | Beta Coef. | Sig. | Beta Coef. | Sig. | Beta Coef. | Sig. | ||
| 1 | Gender (Female): Male | 0.011 | 0.77 | -0.024 | 0.53 | -0.014 | 0.71 | 0.008 | 0.84 |
| 2 | Age | 0.680 | 0.05 | 0.830 | 0.02 | 1.021 | 0.00 | 0.520 | 0.17 |
| Age Squared | -0.745 | 0.03 | -0.955 | 0.01 | -1.068 | 0.00 | -0.528 | 0.16 | |
| 3 | Marital Status (Single & WDS): Married | -0.038 | 0.33 | 0.010 | 0.80 | 0.029 | 0.47 | 0.046 | 0.27 |
| 4 | Education (Not Higher): Higher Education | 0.098 | 0.01 | 0.090 | 0.02 | 0.114 | 0.00 | 0.067 | 0.10 |
| 5 | Ethnicity (White): Non-White | -0.044 | 0.24 | -0.084 | 0.03 | -0.025 | 0.52 | -0.025 | 0.53 |
| 6 | House Ownership (Not Owned): Owned house | 0.118 | 0.00 | 0.123 | 0.00 | 0.112 | 0.00 | 0.140 | 0.00 |
| 7 | Occupation (Non-Working): Working | 0.072 | 0.09 | 0.073 | 0.09 | 0.115 | 0.01 | 0.078 | 0.09 |
| 8 | Income (Don’t Know): <£10,000 | -0.024 | 0.57 | -0.001 | 0.99 | -0.026 | 0.54 | -0.038 | 0.40 |
| £10,000 - £19,999 | 0.075 | 0.11 | 0.069 | 0.14 | 0.027 | 0.56 | 0.017 | 0.74 | |
| £20,000 - £29,999 | 0.072 | 0.11 | 0.033 | 0.46 | 0.020 | 0.66 | -0.009 | 0.84 | |
| £30,000 - £39,999 | 0.072 | 0.10 | 0.076 | 0.08 | -0.021 | 0.64 | -0.039 | 0.40 | |
| £40,000 - 49,999 | 0.049 | 0.23 | 0.033 | 0.42 | -0.010 | 0.81 | 0.035 | 0.42 | |
| £50,000 or more | 0.093 | 0.04 | 0.035 | 0.42 | 0.043 | 0.33 | 0.025 | 0.60 | |
| 9 | Parkinson’s duration (Not Recorded): 2-5 years | -0.036 | 0.48 | -0.027 | 0.60 | 0.065 | 0.22 | 0.043 | 0.44 |
| 5-10 years | -0.091 | 0.10 | -0.087 | 0.12 | -0.020 | 0.72 | -0.054 | 0.36 | |
| 10-15 years | -0.221 | 0.00 | -0.148 | 0.00 | -0.090 | 0.09 | -0.117 | 0.04 | |
| 15-20 years | -0.163 | 0.00 | -0.098 | 0.03 | -0.109 | 0.02 | -0.111 | 0.02 | |
| > 20 years | -0.111 | 0.01 | -0.130 | 0.00 | -0.119 | 0.01 | -0.123 | 0.01 | |
| 10 | Health services visits | -0.189 | 0.00 | -0.203 | 0.00 | -0.165 | 0.00 | -0.137 | 0.00 |
| 11 | Medication | -0.056 | 0.16 | -0.029 | 0.47 | -0.036 | 0.38 | 0.020 | 0.64 |
| 12 | Financial Burden (1st Decile): 2nd Decile (£839) | 0.004 | 0.93 | -0.018 | 0.72 | -0.002 | 0.97 | -0.009 | 0.86 |
| 3rd Decile (£2594) | -0.065 | 0.19 | -0.086 | 0.08 | -0.113 | 0.02 | -0.103 | 0.05 | |
| 4th Decile (£4840) | -0.184 | 0.00 | -0.144 | 0.00 | -0.134 | 0.01 | -0.150 | 0.00 | |
| 5th Decile (£7736) | -0.156 | 0.00 | -0.186 | 0.00 | -0.209 | 0.00 | -0.227 | 0.00 | |
| 6th Decile (£12315) | -0.178 | 0.00 | -0.128 | 0.01 | -0.178 | 0.00 | -0.154 | 0.00 | |
| 7th Decile (£18250) | -0.154 | 0.00 | -0.153 | 0.00 | -0.196 | 0.00 | -0.198 | 0.00 | |
| 8th Decile (£24686) | -0.204 | 0.00 | -0.147 | 0.00 | -0.195 | 0.00 | -0.155 | 0.00 | |
| 9th Decile (£32293) | -0.210 | 0.00 | -0.192 | 0.00 | -0.161 | 0.00 | -0.172 | 0.00 | |
| 10th Decile (£51410) | -0.198 | 0.00 | -0.204 | 0.00 | -0.192 | 0.00 | -0.181 | 0.00 | |
| 1 | Informal carers are interchangeably referred to as carers or caregivers in this paper. |
| 2 | Please refer this report for details on recruitment strategy (overall and for the booster sample) as well as other details of methodology. |
| 3 | Life satisfaction score and happiness score are jointly referred to as the psychological wellbeing scores. |
| 4 | Their study was undertaken for the United Kingdom and Germany. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).